secwatch.observer — SEC 8-K summary
======================================

Issuer:     Insight Molecular Diagnostics Inc. (IMDX)
CIK:        0001642380
Form:       8-K
Filed at:   2023-06-29T23:59:59+00:00
Accession:  0001493152-23-022912
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Oncocyte annual meeting results: directors elected, auditor ratified, say-on-pay approved
--------------------------------------------------------------------------------

- All five board nominees (Riggs, Arno, Kingsley, Last, Silverman) elected; each received >78.8M votes for.
- Ratification of WithumSmith+Brown as auditor approved: 126.4M for, 714K against, 659K abstain.
- Advisory vote on named executive officer compensation passed: 79.0M for, 5.3M against, 128K abstain.
- Turnout was 77.62% (127.8M shares present); broker non-votes 43.4M on director and compensation votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1642380/000149315223022912/0001493152-23-022912-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1642380/000149315223022912/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-022912

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer